IRobot Has a New CEO, and There's a Lot of Work to Do
Robotics Market: Logistics Expansion Drives 135.68 Billion by 2031 Warehouse Automation Boom | SkyQuest Technology
WESTFORD, Mass., June 24, 2024 /PRNewswire/ -- As per SkyQuest, the Global Robotics Market size was valued at USD 34.06 billion in 2022 and is poised to grow from USD 39.71 billion in 2023 to USD 135
Express News | IRobot Names Julien Mininberg to Board of Directors
Express News | IRobot Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
GameStop Reports Earnings Next Week. Who Should Be Worried?
Why Is IRobot (IRBT) Down 8.5% Since Last Earnings Report?
Why IRobot Stock Was Up 12% Last Month
GameStop Halo Effect: These Highly-shorted Consumer Stocks Are Moving up Again
GPRO, IRBT Among Notable Consumer Discretionary Additions to Russell Microcap; PLBY, RMCF Out
Can IRobot Stock Bounce Back After Crashing 72% This Year?
Roomba Robot Vacuums Are up to $425 off for Memorial Day
Down 94% From Its All-Time High, Here Are 2 Things IRobot Needs to Do for Shares to Soar
IRobot Halts Its Roomba Subscription Service as It Gets a New CEO
New Analysts Initiate Coverage: 3 Stocks to Add to Your Portfolio
The initiation of coverage by new analysts can be highly advantageous for investors and has a substantial impact on financial markets.
Insiders Buying Turtle Beach And 3 Other Stocks
Although U.S. stocks closed lower on Thursday, there were a few notable insider trades.When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the sto
IRobot(IRBT.US) Officer Buys US$25,189.17 in Common Stock
$iRobot(IRBT.US)$ Officer Cohen Gary purchased 2,050 shares of common stock on May 15, 2024 at an average price of $12.2874 for a total value of $25,189.17.Source: Announcement What is statement of ch
Express News | IIrobot CEO Gary Cohen Reported Purchase of 2.500 Shares @ Avg Price Of $12.2874/Share
Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) fell sharply during Wednesday's session after the company reported first-quarter financial results.Bolt Biotherapeutics posted a GAAP loss of 28 cent
IRBT and EFOI Among Consumer Discretionary Movers
IRobot Investors Just Got Some Bullish News